The Extraordinary Shareholders' Meeting of ASIT Biotech S.A. approved the appointment of two new Board members with recognized expertise in the field of immunotherapy and biotechs, namely Mr. Louis Champion and Mr. Michel Baijot, following the departure from the Board of Directors of Mr. Gerd Zettlmeissl, Mr. Thierry Legon and Mr. Jean Duchateau. The Board of Directors then approved the appointment of Mr. Louis Champion as Chairman of the Board of Directors and Mr. Michel Baijot as Managing Director, providing the Company with significant expertise of the biotech and big pharma fields.